| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
, -1β, 2 and 6 on ACTH synthesis and release in the mouse pituitary tumour cell line AtT-20
The effects of recombinant human interleukin (rhIL)-1
, -1β, 2 and 6 on the release of ACTH from the ACTH-producing tumour cell line AtT-20 of the mouse were studied during relatively long periods of incubation. Levels of ACTH in the media, measured by radioimmunoassay, were increased by the addition of rhIL-1 or -1β after latent periods of more than 4 h. RhIL-1 and -1β were almost equally potent in this experiment and the minimum, half-maximum and maximum effective concentrations of both rhIL-1 and -1β were about 0·1 pmol/l, 1–3 pmol/l and 10–100 pmol/l respectively. During incubation with rhIL-1β, immunoreactive ACTH levels and mRNA levels of the ACTH precursor pro-opiomelanocortin in cells also increased without apparent changes in the growth rate of the cells. Although the AtT-20 cells used in this study were quite insensitive to human/rat corticotrophin-releasing hormone (CRH), the cells showed a significant response to CRH after incubation with rhIL-1β. RhIL-6 showed similar effects to those of rhIL-1β on ACTH synthesis and release; increasing ACTH in cells and media after a certain latent period. On the other hand, rhIL-2 did not change ACTH levels in the AtT-20 cells in this study. These observations indicate that rhIL-1, -1β and rhIL-6 have direct effects on ACTH-producing cells to stimulate the release and synthesis of ACTH after a latent period.
Journal of Endocrinology (1989) 122, 33–39
This article has been cited by other articles:
|
|
 |
|
  M. N. Silverman, A. H. Miller, C. A. Biron, and B. D. Pearce Characterization of an Interleukin-6- and Adrenocorticotropin-Dependent, Immune-to-Adrenal Pathway during Viral Infection Endocrinology, August 1, 2004; 145(8): 3580 - 3589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Komori, S. Miyahara, M. Yamamoto, T. Matsumoto, K. Zhang, M. Nakagawa, S. Nomura, E. Motomura, T. Shiroyama, and Y. Okazaki Effects of Odorants on the Hypothalamic-Pituitary-Adrenal Axis and Interleukin-6 (IL-6) and IL-6 Receptor mRNA Expression in Rat Hypothalamus after Restraint Stress Chem Senses, November 1, 2003; 28(9): 767 - 771. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Rivest, S. Lacroix, L. Vallières, S. Nadeau, J. Zhang, and N. Laflamme How the Blood Talks to the Brain Parenchyma and the Paraventricular Nucleus of the Hypothalamus During Systemic Inflammatory and Infectious Stimuli Experimental Biology and Medicine, January 1, 2000; 223(1): 22 - 38. [Abstract] [Full Text]
|
|
|
|
|
|
L. Vallières and S. Rivest Interleukin-6 Is a Needed Proinflammatory Cytokine in the Prolonged Neural Activity and Transcriptional Activation of Corticotropin-Releasing Factor during Endotoxemia Endocrinology, September 1, 1999; 140(9): 3890 - 3903. [Abstract] [Full Text]
|
|
|
|
|
|
C. J. Auernhammer, V. Chesnokova, and S. Melmed Leukemia Inhibitory Factor Modulates Interleukin-1{beta}-Induced Activation of the Hypothalamo-Pituitary-Adrenal Axis Endocrinology, May 1, 1998; 139(5): 2201 - 2208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Katahira, Y. Iwasaki, Y. Aoki, Y. Oiso, and H. Saito Cytokine Regulation of the Rat Proopiomelanocortin Gene Expression in AtT-20 Cells Endocrinology, May 1, 1998; 139(5): 2414 - 2422. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Path, S. R. Bornstein, M. Ehrhart-Bornstein, and W. A. Scherbaum Interleukin-6 and the Interleukin-6 Receptor in the Human Adrenal Gland: Expression and Effects on Steroidogenesis J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2343 - 2349. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
